1049 related articles for article (PubMed ID: 18351707)
1. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
Sugaya M; Nishino N; Katoh A; Harada K
J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
[TBL] [Abstract][Full Text] [Related]
2. An isostructural G-G to A-A substitution within the HIV RRE RNA switches the specificity towards arginine-rich peptides.
Aoyama S; Sugaya M; Kobayashi C; Masuda K; Maeda T; Sakamoto T; Kawai G; Katoh A; Harada K
Nucleic Acids Symp Ser (Oxf); 2009; (53):271-2. PubMed ID: 19749365
[TBL] [Abstract][Full Text] [Related]
3. Facile detection of specific RNA-polypeptide interactions by MALDI-TOF mass spectrometry.
Sugaya M; Saito R; Matsumura Y; Harada K; Katoh A
J Pept Sci; 2008 Aug; 14(8):978-83. PubMed ID: 18288633
[TBL] [Abstract][Full Text] [Related]
4. Peptide-triggered conformational switch in HIV-1 RRE RNA complexes.
Gosser Y; Hermann T; Majumdar A; Hu W; Frederick R; Jiang F; Xu W; Patel DJ
Nat Struct Biol; 2001 Feb; 8(2):146-50. PubMed ID: 11175904
[TBL] [Abstract][Full Text] [Related]
5. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
Luedtke NW; Tor Y
Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
[TBL] [Abstract][Full Text] [Related]
7. The amino terminal domain of HIV-1 Rev is required for discrimination of the RRE from nonspecific RNA.
Daly TJ; Doten RC; Rusche JR; Auer M
J Mol Biol; 1995 Oct; 253(2):243-58. PubMed ID: 7563086
[TBL] [Abstract][Full Text] [Related]
8. Interaction of HIV Rev peptides with the Rev response element RNA.
Williamson JR; Battiste JL; Mao H; Frankel AD
Nucleic Acids Symp Ser; 1995; (33):46-8. PubMed ID: 8643394
[TBL] [Abstract][Full Text] [Related]
9. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
Nam YS; Petrovic A; Jeong KS; Venkatesan S
J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
[TBL] [Abstract][Full Text] [Related]
10. Water, shape recognition, salt bridges, and cation-pi interactions differentiate peptide recognition of the HIV rev-responsive element.
Michael LA; Chenault JA; Miller BR; Knolhoff AM; Nagan MC
J Mol Biol; 2009 Sep; 392(3):774-86. PubMed ID: 19631217
[TBL] [Abstract][Full Text] [Related]
11. Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif.
Chaloin L; Smagulova F; Hariton-Gazal E; Briant L; Loyter A; Devaux C
J Biomed Sci; 2007 Sep; 14(5):565-84. PubMed ID: 17520355
[TBL] [Abstract][Full Text] [Related]
12. Selection of RNA-binding peptides in vivo.
Harada K; Martin SS; Frankel AD
Nature; 1996 Mar; 380(6570):175-9. PubMed ID: 8600395
[TBL] [Abstract][Full Text] [Related]
13. Randomized codon mutagenesis reveals that the HIV Rev arginine-rich motif is robust to substitutions and that double substitution of two critical residues alters specificity.
Possik EJ; Bou Sleiman MS; Ghattas IR; Smith CA
J Mol Recognit; 2013 Jun; 26(6):286-96. PubMed ID: 23595810
[TBL] [Abstract][Full Text] [Related]
14. Structural change in Rev responsive element RNA of HIV-1 on binding Rev peptide.
Peterson RD; Feigon J
J Mol Biol; 1996 Dec; 264(5):863-77. PubMed ID: 9000617
[TBL] [Abstract][Full Text] [Related]
15. Structural dynamics of HIV-1 Rev and its complexes with RRE and 5S RNA.
Lam WC; Seifert JM; Amberger F; Graf C; Auer M; Millar DP
Biochemistry; 1998 Feb; 37(7):1800-9. PubMed ID: 9485305
[TBL] [Abstract][Full Text] [Related]
16. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
Luedtke NW; Liu Q; Tor Y
Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of HIV-1 Rev-RRE interaction by diphenylfuran derivatives.
Ratmeyer L; Zapp ML; Green MR; Vinayak R; Kumar A; Boykin DW; Wilson WD
Biochemistry; 1996 Oct; 35(42):13689-96. PubMed ID: 8885849
[TBL] [Abstract][Full Text] [Related]
18. Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.
Shimane K; Kodama EN; Nakase I; Futaki S; Sakurai Y; Sakagami Y; Li X; Hattori T; Sarafianos SG; Matsuoka M
Int J Biochem Cell Biol; 2010 Sep; 42(9):1482-8. PubMed ID: 20580677
[TBL] [Abstract][Full Text] [Related]
19. Evolvability of the mode of peptide binding by an RNA.
Iwazaki T; Li X; Harada K
RNA; 2005 Sep; 11(9):1364-73. PubMed ID: 16043495
[TBL] [Abstract][Full Text] [Related]
20. Structure of the HIV-1 Rev response element alone and in complex with regulator of virion (Rev) studied by atomic force microscopy.
Pallesen J; Dong M; Besenbacher F; Kjems J
FEBS J; 2009 Aug; 276(15):4223-32. PubMed ID: 19583776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
